Apellis Pharmaceuticals Announces Private Placement of Convertible Senior Notes

NEXT STORY
CB2 Insights Announces Unaudited Profitability in April and Continued Execution of its Business Plan
PREV STORY
Evelo Biosciences, Rutgers University, and Robert Wood Johnson University Hospital Announce Submission of IND for a Phase 2 Study of EDP1815 in COVID-19 Patients
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Ascendis Pharma A/S Announces Submission of Biologics License Application (BLA) to FDA for TransCon™ hGH in Pediatric Growth Hormone Deficiency

author_avatar
NASDAQ Market News

Mustang Bio and City of Hope Announce First Patient Dosed in Phase 1 Clinical Trial of MB-101 (IL13Rα2-specific CAR T cells) to Treat Leptomeningeal Brain Tumors

author_avatar
NASDAQ Market News

TiGenix provides update on proposed initial public offering in the United States

Leuven, Belgium, Oct. 26, 2016 (GLOBE NEWSWIRE) -- TiGenix NV (Euronext Brussels: TIG; the ...

author_avatar
NASDAQ Market News